Roche in Neuroscience & Rare Disease: Preserving what makes people who they are

With a strong and diverse portfolio covering the most common to the rarest neurological conditions, Roche is approaching neuroscience and rare disease with the same curiosity, passion and rigor as we have done in oncology. Our mission is rooted in our formula: follow the science to improve the lives of people.

Find out more

Rare diseases

Find out what makes a rare disease rare and who is affected.

MS is a disease of the central nervous system, estimated to affect 2.3 million people worldwide.

SMA affects approximately 1 in 11,000 live births worldwide. Find out more about the condition and the role of the SMN protein.

Downloads: Download3 MB

Spinal muscular atrophy

Learn how we are breaking down barriers that prevent patients from joining clinical trials for spinal muscular atrophy.

“Do not take life for granted. Take every moment in.”

How patient partnership is shaping the future of research and clinical development for Huntington’s disease.

Alzheimer’s disease is a progressive, fatal brain disease and the most common cause of dementia.

HD affects approximately 1 in 10,000 people.

Find out more about this disease and how it impacts daily life?

Downloads: Download1 MB

Huntington’s disease – Advancing research to improve lives

Huntington’s disease can affect entire families, and much is still unknown about this complex brain disease, but through research, we hope to change that.

Roche in Neuroscience & Rare Disease: Preserving what makes people who they are

Rare diseases

Multiple sclerosis

Spinal muscular atrophy

Spinal muscular atrophy

Neuromyelitis optica spectrum disorder

Elevating the patient voice in Huntington’s disease

Alzheimer’s disease

Huntington’s disease

HD affects approximately 1 in 10,000 people.

Huntington’s disease – Advancing research to improve lives